Abdel Babiker

Determinants of survival following HIV-1 seroconversion after the introduction of HAART

Kholoud Porter, Abdel Babiker, Krishnan Bhaskaran et al. · The Lancet · 2003 · 370 citations

Hiv-1 Seroconversion, Viral Persistence, Human Retrovirus +9

HIV-1 DNA predicts disease progression and post-treatment virological control

James P. Williams, Jacob Hurst, Wolfgang Stöhr et al. · eLife · 2014 · 302 citations · Full text

Viral Persistence, Virus Rebound, Medicine +10

An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses

Alexandre Harari, Pierre‐Alexandre Bart, Wolfgang Stöhr et al. · The Journal of Experimental Medicine · 2008 · 293 citations · Full text

Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan

A. M. A. El Hassan, EE Zijlstra, MM Mukhtar et al. · The Lancet · 2000 · 232 citations

Vaccination, Vaccine Development, Vaccine Target +6

Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial

MF Gomes, MA Faiz, John O. Gyapong et al. · The Lancet · 2008 · 225 citations · Full text

Malaria, Patient Safety, Placebo-controlled Trial +3